Analyst Ratings for Eagle Pharmaceuticals Inc. (EGRX)

Updated: 2017-07-28

An average rating of Overweight has been given to Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) by analysts covering the stock. EGRX had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 3 analysts, 0 gave an overweight rating, 0 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Many analysts weighed in on price targets for EGRX. The highest price target was 118, implying a possible profit of 132.47 percent. The lowest price target was 57, implying a possible loss of 12.29 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -23.85 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -6.27 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, which can be compared to the 0 analysts that decreased their estimates. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of EGRX's earnings is estimated by analysts to be -46.64 percent. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Smaller PEG ratios are desirable, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of EGRX is -0.17.

EGRX has a 52-week high of 97.15 and a 52-week low of 42.33. Today's price is 19.91 percent above the 52-week low, and below the high by 47.75 percent. EGRX has a price/earnings ratio of 7.87. Investors typically compare the P/E ratio to a company's peers in the industry. The EGRX value stock report compares EGRX to some of its peers using value stock charts. The market cap of EGRX is $0.80613 billion. EGRX's next earnings release will be on 0000-00-00, which is days away.